SEC Form 4 Reporting Owner · CIK 0001932843
David E. Lazar
CEO at Aterian Inc · CEO at Quantum Cyber N V · Director at Sow Good Inc · +8 more
Bought (12 mo)
—
Sold (12 mo)
−$12M
Form 4 Filings
31
Companies
11
Filing Activity
2026-09-30
first filed 2022-07-08
Trading record
Open-market buys
+$5.18M
6 filings
Open-market sales
−$22.2M
9 filings
Sales under a 10b5-1 plan
0%
0 of 9 sale filings
Companies
| Company | Role | Filings | Bought | Sold | Net | Holding after latest filing |
|---|---|---|---|---|---|---|
| ATERAterian Insider trading | CEO | 3 | — | — | — | 8,038,030 2026-09-30 |
| QUCYQuantum Cyber Insider trading | CEO | 3 | — | — | — | 55,057,500 2026-08-07 |
| SOWGSow Good Insider trading | Director | 2 | — | — | — | 5,740,000 2026-04-02 |
| INDPIndaptus Therapeutics Insider trading | Director | 1 | — | — | — | — |
| NBYStablecoin Development Insider trading | 10%+ | 2 | — | — | — | 6,388,000 2026-01-29 |
| KALAKala Bio Insider trading | CEO | 2 | — | — | — | 0 2025-12-22 |
| CYCCBio Green Med Insider trading | 10%+ | 3 | — | 194,635,570 | −194,635,570 | 155,838 2025-08-04 |
| LQRLQR House Insider trading | President | 2 | — | 1,101,818 | −1,101,818 | 100,000 2025-04-07 |
| MINMFiEE Insider trading | Director | 5 | 1,456,980 | — | +1,456,980 | 2,681,980 2025-03-10 |
| OPGNCapForce Insider trading | CEO | 4 | — | — | — | 100,000 2024-04-12 |
| TTNPTitan Pharmaceuticals Insider trading | CEO | 4 | 2,283,690 | 3,747,968 | −1,464,278 | 100,000 2023-07-31 |
Common-stock shares bought and sold on the open market, as reported on Form 4. The holding is what the latest filing at each company reported owning after its transactions.
Also files as
13D/G Beneficial owner of 5% or more · 9 open stakes (1 reported closed)
| Company | Schedule | % of class | Filed |
|---|---|---|---|
| Aterian | 13D | 3.1% | 2026-09-30 |
| Quantum Cyber | 13D | 94.3% | 2026-08-07 |
| KALA BIO Inc | 13D | 3.9% | 2026-07-02 |
| Indaptus Therapeutics | 13D | 47.9% | 2026-03-24 |
| KALA BIO Inc | 13D | 5.2% | 2026-02-06 |